Optimized antibodies that target CD19

Details for Australian Patent Application No. 2011203503 (hide)

Owner Xencor, Inc.

Inventors Bernett, Matthew J.; Chu, Seung Yup; Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan; Pong, Erik WeiKing; Richards, John O.; Zhukovsky, Eugene Alexander

Agent Davies Collison Cave

Pub. Number AU-A-2011203503

Parent 2007285976

Filing date 11 July 2011

Wipo publication date 28 July 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

28 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203503

28 July 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203504-Animal ectoparasite-controlling agent

2011203502-Animal ectoparasite-controlling agent